Walleye Capital LLC Precigen, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.99 - $6.55 $52,375 - $68,748	-10,496 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.24 - $8.22 $65,495 - $86,277	10,496 New	10,496 $68,000
Q2 2020 Aug 14, 2020	SELL	$2.16 - $5.46 $37,523 - $94,851	-17,372 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $25,363 - $124,904	17,372 New	17,372 $59,000

144

160M

136K

4.8K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $377M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.